The company said automation was the cause. The union says blamed it on call centers in the Philippines. In any event, 200 are losing their jobs.
Often, what is billed as a $300 million strategic partnership between Big Pharma and a small drug developer winds up in an amicable split years down the road with substantially less cash having changed hands.
That’s what makes yesterday’s announcement by Fort Washington’s Vitae Pharmaceuticals Inc....
WASHINGTON - The Justice Department yesterday accused Wyeth, one of the nation's biggest drugmakers, of cheating Medicaid programs out of hundreds of millions of dollars by overcharging for a stomach-acid drug.
The Philadelphia area ranks behind only Boston in terms of the vibrancy of its life-sciences industry, according to a new national study.
Revolutionary medical advances will force dramatic changes in the ways that drugs are tested and approved and will require pharmaceutical companies to overhaul their businesses, the outgoing head of the U.S. Food and Drug Administration said yesterday.
Will yesterday's news that Merck's Gardasil vaccine may protect men, as well as women, from a deadly virus bolster sales of a product that so far has failed to fulfill its maker's hopes for a blockbuster?
MUNICH, Germany - Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday.
Emmanuel Skordalakes scrutinized the genetic makeup of pigs and cows and rats and hundreds of other creatures before the red flour beetle, an eighth-of-an-inch-long pest found in Southern kitchens, delivered the breakthrough scientists had sought for more than a decade.
A drug's name contributes so much to its image and sales that companies spend millions on concocting syllable combinations and consumer research.
PHILADELPHIA - Lannett Company Inc., a manufacturer of generic pharmaceuticals, said that its wholly owned subsidiary, Cody Laboratories, has received approval from the U.S. Drug Enforcement Administration to directly import raw materials for processing into controlled substance medication for pain...
PARIS - Sanofi-Aventis SA said its planned $551 million acquisition of Acambis PLC will bolster its leading position in the vaccine market and strengthen its development pipeline.
NEW YORK - Wall Street fluctuated today as investors worried about earnings at drug makers Merck & Co. and Schering-Plough Corp.
TRENTON - Drugmaker Merck & Co. said today that it will fund the $4.85 billion settlement expected to resolve roughly 50,000 lawsuits related to its Vioxx painkiller, with initial payments to former users of the withdrawn drug beginning late next month.
GlaxoSmithKline and Actelion Ltd announced today that they will collaborate on Actelion's treatment for sleep disorders.